Citadel Advisors

Citadel Advisors’s Enliven Therapeutics ELVN Stock Holding History

Citadel Advisors’s Portfolio ELVN Stock Details ELVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$68.4M	Buy	1,743,915 +319,571	+22%	+$8.85M	0.05%	1100
2025 Q4	$21.9M	Buy	1,424,344 +263,841	+23%	+$5.26M	0.01%	2246
2025 Q3	$23.8M	Sell	1,160,503 -309,921	-21%	-$6.25M	0.02%	2120
2025 Q2	$29.5M	Buy	1,470,424 +347,286	+31%	+$6.57M	0.03%	1697
2025 Q1	$22.1M	Sell	1,123,138 -615,394	-35%	-$13.2M	0.02%	1930
2024 Q4	$39.1M	Buy	1,738,532 +4,555	+0.3%	+$118K	0.04%	1502
2024 Q3	$44.3M	Sell	1,733,977 -573,837	-25%	-$13.3M	0.05%	1331
2024 Q2	$53.9M	Sell	2,307,814 -46,589	-2%	-$981K	0.05%	1097
2024 Q1	$41.4M	Sell	2,354,403 -40,045	-2%	-$614K	0.04%	1378
2023 Q4	$33.1M	Buy	2,394,448 +42,957	+2%	+$526K	0.03%	1522
2023 Q3	$32.1M	Buy	2,351,491 +55,281	+2%	+$931K	0.03%	1442
2023 Q2	$46.9M	Hold	2,296,210	–	–	0.05%	1106
2023 Q1	$50.3M	Buy	2,296,210 +2,102,014	+1,082%	+$42.8M	0.06%	1056
2022 Q4	$3.18M	Buy	194,196 +170,360	+715%	+$2.72M	﹤0.01%	4663
2022 Q3	$217K	Buy	+23,836	New	+$141K	﹤0.01%	10249
2020 Q2	–	Sell	-7,942	Closed	-$509K	–	9961
2020 Q1	$509K	Buy	+7,942	New	+$506K	﹤0.01%	6437

Other funds holding ELVN

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return